If You Invested in Liminatus Pharma (LIMNW)
Looking for the live price? See the LIMNW quote & overviewWhat $1,000 or $10,000 in LIMNW Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since May 1, 2025 |
|---|---|---|---|---|
| $1,000 | $360 -64% | — | — | $456 -54% |
| $10,000 | $3,599 -64% | — | — | $4,559 -54% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for LIMNW$1,000 Investment Over Time
LIMNW vs S&P 500Year-by-Year Returns
LIMNW annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2025 | $0.11 | $0.04 | -68.2% | -68.2% |
| 2026 | $0.04 | $0.05 | +38.3% | -54.4% |
About Liminatus Pharma
Biological Products, (no Diagnostic Substances) · NASDAQ
Frequently Asked Questions
Liminatus Pharma investment returns
How much would $1,000 invested in Liminatus Pharma be worth today?
If you invested $1,000 in Liminatus Pharma (LIMNW) 1 years ago on 2025-07-09, your investment would be worth $360 today, representing a -64.0% total return, growing at a compounded rate of -64.1% per year (CAGR).
Has Liminatus Pharma outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare LIMNW performance over available time periods.
What is Liminatus Pharma's average annual return?
The compound annual growth rate (CAGR) of LIMNW over the past 1 years is -64.1%, growing at a compounded rate each year. Individual years vary significantly — LIMNW's best recent year was 2026 (+38.3%) and worst was 2025 (-68.2%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
